Tag Archives: specialty care

EIB Provides €150 Million to Fuel Alfasigma’s 2025–2027 R&D in Specialty and Rare-Disease Medicines

(IN BRIEF) The EIB has extended a €150 million loan to Alfasigma to fund its R&D efforts from 2025 to 2027, targeting new drugs in gastroenterology, hepatology, vascular medicine, rheumatology, and rare diseases. The financing, endorsed by EIB Vice-President Gelsomina … Read the full press release

Sidekick Health Secures €35 Million Funding from EIB to Expand Digital Therapeutics and AI Capabilities

(IN BRIEF) Sidekick Health has secured a €35 million venture debt facility from the European Investment Bank (EIB) to advance its digital health and therapeutics initiatives. The funding, backed by the European Commission’s InvestEU initiative, will accelerate R&D and AI-driven … Read the full press release